XML 19 R8.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Operating activities:    
Net (loss) income $ (2,328) $ 27,839
Adjustments to reconcile net (loss) income to net cash provided by (used in) operating activities:    
Income from discontinued operations, net of taxes (191) (107)
Loss on disposal of discontinued operations, net of taxes 404 0
Equity in net loss of limited liability investments 60 34
Depreciation and amortization expense 1,540 1,492
Stock-based compensation expense 320 283
Net realized gains (124) (210)
Loss (gain) on change in fair value of equity investments 3 (1,075)
Loss on change in fair value of limited liability investments, at fair value 8 130
Impairment of intangible assets 511 (0)
Loss (gain) on change in fair value of debt 80 (309)
Loss on change in fair value of derivatives 49 1,446
Loss on change in fair value of contingent consideration 270 0
Deferred income taxes (69) 84
Amortization of fixed maturities premiums and discounts (6) 14
Gain on extinguishment of debt 0 (31,616)
Changes in operating assets and liabilities:    
Service fee receivable, net (440) (249)
Other receivables, net 331 1,146
Deferred contract costs (59) (227)
Other assets 18 465
Deferred service fees 7 (346)
Other, net (179) (21,631)
Cash provided by (used in) operating activities - continuing operations 205 (22,837)
Cash provided by operating activities - discontinued operations 44 50
Net cash provided by (used in) operating activities 249 (22,787)
Investing activities:    
Proceeds from sales and maturities of fixed maturities 1,095 2,316
Proceeds from sales of equity investments 77 0
Purchases of fixed maturities (1,276) (1,471)
Net proceeds from limited liability investments 0 98
Net proceeds from limited liability investments, at fair value 115 5,306
Net proceeds from investments in private companies 9 0
Net proceeds from other investments and short-term investments 4 7
Net purchases of property and equipment (190) (5)
Cash (used in) provided by investing activities - continuing operations (166) 6,251
Cash used in investing activities - discontinued operations 0 0
Net cash (used in) provided by investing activities (166) 6,251
Financing activities:    
Proceeds from exercise of warrants 0 6,294
Cash paid for repurchase of common stock (64) 0
Distributions to noncontrolling interest holders 0 (3,584)
Principal proceeds from bank loans, net of debt issuance costs of $26 4,174 0
Principal payments on bank loans (1,626) (3,251)
Purchase of subordinated debt 0 (40,328)
Payment of debt issuance costs 0 (25)
Cash provided by (used in) financing activities - continuing operations 2,484 (40,894)
Cash used in financing activities - discontinued operations (130) (126)
Net cash provided by (used in) financing activities 2,354 (41,020)
Net increase (decrease) in cash and cash equivalents and restricted cash from continuing operations 2,523 (57,480)
Cash and cash equivalents and restricted cash at beginning of period 18,110 77,802
Less: cash and cash equivalents and restricted cash of discontinued operations 612 570
Cash and cash equivalents and restricted cash of continuing operations at beginning of period 17,498 77,232
Cash and cash equivalents and restricted cash of continuing operations at end of period 20,021 19,752
Cash and cash equivalents 12,112 8,291
Restricted cash 7,909 11,461
Cash and cash equivalents and restricted cash per statements of cash flows $ 20,021 $ 19,752